Substantial investments were made in population based biobanks over the past decade. Ethnocultural community members are both sponsors and beneficiaries of biobanks. In addition, the success of biobank projects depends on community support and participation. Yet there are few empirical data on views, perceptions and interests of ethnocultural communities on biobanks. This silent gap in genomics, ethics and policy literatures has to be addressed. We conducted a qualitative research study with in-depth interviews of ethnocultural community leaders (e.g., members of the Canadian Parliament, school commissioners) on their perspectives concerning population specific genomics research and biobanks. An equal partnership model where public is not only informed, but also involved in decision-making processes was perceived as an essential democratic requisite. These empirical data on ethnocultural community leaders’ views, interests and perceptions identify several key socio-cultural and ethical factors that can be decisive for effective and sustainable community involvement in biobanks.
Ahmed, S., Atkin, K., Hewison, J. and Green, J. ( 2006) "The Influence of Faith and Religion and the Role of Religious and Community Leaders in Prenatal Decisions for Sickle Cell Disorders and Thalassaemia Major," Prenatal Diagnosis26: 801-9.
2.
Barnoy, S., Ehrenfeld, M., Sharon, R. and Tabak, N. ( 2006) "Knowledge and Attitudes toward Human Cloning in Israel ," New Genetics and Society25(1): 21-31.
3.
Berry, J. ( 2006) "Mutual Attitudes among Immigrants and Ethnocultural Groups in Canada," International Journal of Intercultural Relations30: 719-34.
4.
Brunk, C.G. ( 2006) "Public Knowledge, Public Trust: Understanding the ‘Knowledge Deficit,’" Community Genetics9: 178-83.
5.
Burton, B. ( 2002) "Proposed Genetic Database on Tongans Opposed," British Medical Journal324: 443.
Canadian Institutes of Health Research (2007 ) "Guidelines for Health Research Involving Aboriginal People," URL: http://www.cihr-irsc.gc.ca/e/documents/ethics_aboriginal_guidelines_e.pdf
8.
Carlson, R.J. ( 2008) "Preemptive Public Policy for Genomics," Journal of Health Politics, Policy and Law33(1): 39-51.
9.
Collins, F.S., Green, E.D., Guttmacher, A.E. and Guyer, M.S. ( 2003) "A Vision for the Future of Genomics Research," Nature422: 835-47.
10.
Condit, C., Templeton, A., Benjamin, R.B., Bevan, J. and Harris, T.M. ( 2003) "Attitudinal Barriers to Delivery of Race-targeted Pharmacogenomics among Informed Lay Persons," Genetics in Medicine5(5): 385-92.
11.
Dalton, R. ( 2002) "Tribe Blasts ‘Exploitation’ of Blood Samples ," Nature420(14): 111.
12.
David, P.A. and Foray, D. ( 2002) "An Introduction to the Economy of the Knowledge Society ," International Social Science Journal54: 9-23.
13.
Egalite, N., Ozdemir, V. and Godard, B. ( 2007) "Pharmacogenomics Research Involving Racial Classification: Qualitative Research Findings on Researchers’ Views, Perceptions and Attitudes towards Socio-ethical Responsibilities," Pharmacogenomics8: 1115-26.
14.
Einsiedel, E. and Timmermans, F. ( 2005) Crossing Over: Genomics in the Public Arena. Calgary: University of Calgary Press.
15.
Emmanuel, E. ( 1996) "Where Civic Republicanism and Deliberative Democracy Meet," Hastings Center Report26: 12-14.
16.
Gbadegesin, S. and Wendler, D. ( 2006) "Protecting Communities in Health Research from Exploitation ," Bioethics20(5): 248-53.
17.
Godard, B., Marshall, J. and Laberge, C. ( 2007) "Community Engagement in Genetic Research: Results of the First Public Consultation for the Quebec CARTaGENE Project," Community Genetics10: 147-58.
18.
Gottweis, H. and Peterson, A. ( 2008) Biobanks: Governance in Comparative Perspective. London: Routledge.
19.
Graves, S.C., Kletter, D.B. and Hetzel, W.B. ( 1998) "A Dynamic Model for Requirements Planning with Application to Supply Chain Optimization," Operations Research46: S35-S49.
20.
Guest, G., Bunge, A. and Johnson, L. ( 2006) "How Many Interviews are Enough? An Experiment with Data Saturation and Variability," Field Methods18: 59-82.
21.
Hayry, M. ( 2007) The Ethics and Governance of Human Genetic Databases: European Perspectives. Cambridge: Cambridge University Press.
22.
Healy, S. ( 2008) "Toward an Epistemology of Public Participation," Journal of Environmental Management8: 1644-54.
23.
Human Genetics Commission (2001) " Public Attitudes to Human Genetics," URL: http://www.hgc.gov.uk/
24.
Human Genetics Commission (2002) " Inside Information: Balancing Interests in the use of Personal Genetic Data ," URL: http://www.hgc.gov.uk/
25.
Juengst, E.T. ( 2004) "FACE Facts: Why Human Genetics Will Always Provoke Bioethics ," Journal of Law, Medicine and Ethics32: 267-75.
26.
Khoury, M.J., Gwinn, M., Yoon, P.W., Dowling, N., Moore, C.A. and Bradley, L. ( 2007) "The Continuum of Translation Research in Genomic Medicine: How Can We Accelerate the Appropriate Integration of Human Genome Discoveries into Health Care and Disease Prevention?," Genetics in Medicine9(10): 665-74.
27.
Knoppers, B. M., ed. (2003) Populations and Genetics: Legal and Socio-ethical Perspectives. Leiden and Boston: Martinus Nijhoff Publishers.
28.
Kymlicka, W. and Norman, W. ( 1994) "Return of the Citizen: A Survey of Recent Work on Citizenship Theory," Ethics104: 352-81.
29.
Levitt, M. ( 2007) "Forensic Databases: Benefits and Ethical and Social Costs ," British Medical Bulletin83: 235-48.
30.
McGregor, J.L. ( 2007) "Population Genomics and Research Ethics with Socially Identifiable Groups," Journal of Law, Medicine and Ethics35(3): 356-70.
31.
Malterud, K. ( 2001) "Qualitative Research: Standards, Challenges, and Guidelines ," Lancet358(9280): 483-8.
32.
Mays, N. and Pope, C. ( 1995) "Qualitative Research: Rigour and Qualitative Research ," British Medical Journal311(6997): 109-12.
33.
Medical Research Council and Wellcome Trust ( 2000) "Public Perception of the Collection of Human Biological Samples," URL: http://www.ukbiobank.ac.uk/documents/perceptions.pdf
34.
Miller, J.D. ( 1998) "The Measurement of Civic Scientific Literacy," Public Understanding of Science7: 203-23.
35.
Natale-Pereira, A., Marks, J., Vega, M., Mouzon, D., Hudson, S.V. and Salas-Lopez, D. ( 2008) "Barriers and Facilitators for Colorectal Cancer Screening Practices in the Latino Community: Perspectives From Community Leaders," Cancer Control15(2): 157-65.
36.
National Bioethics Advisory Commission (1999 ) Research Involving Human Biological Materials: Ethical Issues and Policy Guidance. Rockville: Government Printing Office.
37.
National Institutes of Health (2002) "Points to Consider When Planning a Genetic Study that Involves Members of Named Populations," URL: http://www.nih.gov/sigs/bioethics/named_populations.html
38.
Ozdemir, V. and Godard, B. ( 2007) "Evidence Based Management of Nutrigenomics Expectations and ELSIs," Pharmacogenomics8: 1051-62.
39.
Ozdemir, V., Williams-Jones, B., Cooper, D.M., Someya, T. and Godard, B. ( 2007) "Mapping Translational Research in Personalized Therapeutics: From Molecular Markers to Health Policy," Pharmacogenomics8: 177-85.
40.
Ozdemir, V., Graham, J.E. and Godard, B. ( 2008) "Race as a Variable in Pharmacogenomics Science: From Empirical Ethics to Publication Standards," Pharmacogenetics and Genomics18(10): 837-41.
41.
Pullen-Smith, B., Carter-Edwards, L. and Leathers, K.H. ( 2008) "Community Health Ambassadors: A Model for Engaging Community Leaders to Promote Better Health in North Carolina," Public Health Management Practice14: S73-S81.
42.
Rosenthal, J.P. ( 2006) "Politics, Culture, and Governance in the Development of Prior Informed Consent in Indigenous Communities," Current Anthropology47(1): 119-42.
43.
Scheuner, M.T., Sieverding, P. and Shekelle, P.G. ( 2008) "Delivery of Genomic Medicine for Common Chronic Adult Diseases: A Systematic Review," Journal of the American Medical Association299(11): 1320-34.
44.
Sharp, R.R. and Foster, M.W. ( 2002) "Community Involvement in the Ethical Review of Genetic Research: Lessons from American Indian and Alaska Native Populations," Environmental Health Perspectives110(suppl.2): 145-8.
45.
Sharp, R. and Foster, M.W. ( 2007) "Grappling with Groups: Protecting Collective Interests in Biomedical Research," Journal of Medicine and Philosophy32: 321-37.
46.
Shickle, D., Hapgood, R., Carlisle, J., Shackley, P., Morgan, A. and McCabe, C. ( 2003) "Public Attitudes to Participating in UK BioBank: A DNA Bank, Lifestyle and Morbidity Database on 500,000 Members of the UK Public Aged 45-69," in B. M. Knoppers (ed.) Populations and Genetics: Legal and Socio-ethical Perspectives, pp. 323-44. Leiden and Boston: Martinus Nijhoff Publishers.
Sturgis, P., Cooper, H. and Fife-Schaw, C. ( 2005) "Attitudes to Biotechnology: Estimating the Opinions of a Better-informed Public," New Genetics and Society24(1): 31-56.
49.
Thibault, A., Lequin, M. and Tremblay, M. ( 2000) Cadre de référence de la participation publique (Démocratique, utile et crédible). Québec : Conseil de la santé et du bien-être Gouvernement du Québec.
50.
Zdrojewskia, T., Babinska, Z., Kakol, M., Januszko, W., Rutkowski, M., Bandosz, P., Piwonski, J., Krupa-Wojciechowska, B. and Wyrzykowski, B. ( 2006) "How to Improve Cooperation with Political Leaders and other Decision-makers to Improve Prevention of Cardiovascular Disease: Lessons from Poland," European Journal of Cardiovascular Prevention and Rehabilitation13(3): 319-24.
